Sodium–glucose cotransporter 2 inhibitor‐induced changes in body composition and simultaneous changes in metabolic profile: 52‐week prospective <scp>LIGHT</scp> (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study
Cited by 120
Related Papers
Clinical Aspects of Primary Thyroid Lymphoma: Diagnosis and Treatment Based on Our Experience of 119 Cases
|Thyroid|1993|318
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
|Diabetes Care|2019|282
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
|European Heart Journal|2019|229